← Leaderboards
Nathaniel Mabe
Duke University
$823,217
Attributed
$823,217
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2018–25$250K$187.5K$125K$62.5K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$823,217 · 4
By mechanism
R00$491,167 · 1
K99$147,150 · 1
F32$137,784 · 1
F31$47,116 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Ashutosh Chilkoti$32,367,884
- Joshua Clair Snyder$3,740,542
- Everett James Moding$1,712,825
- Emily Amber Snavely$99,990
- Tomi F Akinyemiju$9,093,478
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsGenesPathway InteractionsResponseDesignGenetic TranscriptionRegulationTumorDown-RegulationEpigenetic ProcessNeuroblastoma CellChemoresistanceImmunotherapyIn VivoHigh RiskLinkMemberEnzymesMalignant Childhood NeoplasmMesenchymalCell SurfaceGangliosidesCombinatorialAdrenergic Agents
Grant awards (8)
Defining PRC1.1 as a gatekeeper of lineage plasticity and response to anti-GD2 therapy$242,168
R00 · FY2025 · CA · contact PI
Defining PRC1.1 as a gatekeeper of lineage plasticity and response to anti-GD2 therapy$248,999
R00 · FY2024 · CA · contact PI
Defining PRC1.1 as a gatekeeper of lineage plasticity and response to anti-GD2 therapy$147,150
K99 · FY2023 · CA · contact PI
Elucidating the Role of Epigenetic Plasticity in anti-GD2 Immunotherapy Response$69,674
F32 · FY2022 · CA · contact PI
Elucidating the Role of Epigenetic Plasticity in anti-GD2 Immunotherapy Response$2,500
F32 · FY2022 · CA · contact PI
Elucidating the Role of Epigenetic Plasticity in anti-GD2 Immunotherapy Response$65,610
F32 · FY2021 · CA · contact PI
The Role of Epigenetic Plasticity in Breast Cancer Recurrence$11,380
F31 · FY2019 · CA · contact PI
The Role of Epigenetic Plasticity in Breast Cancer Recurrence$35,736
F31 · FY2018 · CA · contact PI